Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

Intravenous (IV) stem cell delivery for regenerative tissue therapy has been increasingly used in both experimental and clinical trials. However, recent data suggest that the majority of administered stem cells are initially trapped in the lungs. We sought to investigate variables that may affect th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fischer, Uwe M., Harting, Matthew T., Jimenez, Fernando, Monzon-Posadas, Werner O., Xue, Hasen, Savitz, Sean I., Laine, Glen A., Cox, Charles S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc. 2009
Materias:
Seminal Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3190292/
https://ncbi.nlm.nih.gov/pubmed/19099374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2008.0253
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares